SHC Sotera Health Co
Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1822479 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.9%
TTM net income YoY213.0%
TTM EPS YoY200.0%
Revenue 3-yr CAGR7.5%
Net income 3-yr CAGR—
Margins
Gross margin54.6%
Operating margin—
Net margin14.1%
FCF margin11.0%
EBITDA margin—
Returns
ROE27.0%
ROA5.3%
ROIC (approx.)—
Asset turnover0.37x
Leverage & solvency
Liabilities / assets78.4%
Debt / equity2.91x
Current ratio3.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.91x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue16.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $324.89M | $321.38M | $280.05M | $303.44M | $311.31M | $294.34M | $254.52M | $290.20M |
| Cost of revenue | $144.10M | $143.41M | $132.98M | $137.52M | $133.75M | $127.72M | $119.09M | $125.84M |
| Gross profit | $180.79M | $177.96M | $147.07M | $165.92M | $177.56M | $166.62M | $135.43M | $164.37M |
| SG&A expense | $64.14M | $68.16M | $68.21M | $57.51M | $63.29M | $68.89M | $63.06M | $61.84M |
| Operating income | — | — | — | — | — | — | — | $87.15M |
| Pretax income | $83.73M | $78.05M | $42.61M | $70.50M | $72.94M | $18.90M | -$14.82M | $44.96M |
| Income tax | $25.34M | $24.41M | $16.02M | $35.65M | $24.54M | $10.94M | -$1.56M | $32.64M |
| Net income | $58.39M | $53.64M | $26.59M | $34.85M | $48.40M | $7.96M | -$13.26M | $12.32M |
| EBITDA | — | — | — | — | — | — | — | $107.86M |
| EPS (basic) | 0.20 | 0.19 | 0.09 | — | 0.17 | 0.03 | -0.05 | — |
| EPS (diluted) | 0.20 | 0.19 | 0.09 | — | 0.17 | 0.03 | -0.05 | — |
| Weighted avg. shares (diluted) | 289.22M | 288.15M | 287.62M | — | 286.75M | 285.76M | 283.56M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $412.38M | $356.72M | $314.15M | $344.62M | $301.03M | $334.27M | $306.08M | $278.87M |
| Receivables | $152.77M | $150.54M | $137.26M | $139.33M | $142.39M | $136.56M | $128.07M | $140.33M |
| Inventory | $49.63M | $56.37M | $57.49M | $54.38M | $49.87M | $59.95M | $61.05M | $49.16M |
| Current assets | $701.03M | $646.46M | $585.97M | $613.41M | $577.82M | $608.17M | $554.99M | $526.04M |
| PP&E, net | $1.20B | $1.17B | $1.14B | $1.13B | $1.09B | $1.08B | $1.05B | $1.04B |
| Goodwill | $1.09B | $1.09B | $1.10B | $1.10B | $1.10B | $1.10B | $1.08B | $1.08B |
| Intangibles | $264.84M | $270.17M | $279.36M | $288.23M | $290.86M | $300.11M | $300.30M | $317.65M |
| Total assets | $3.39B | $3.31B | $3.24B | $3.26B | $3.19B | $3.22B | $3.10B | $3.07B |
| Current liabilities | $223.69M | $231.24M | $207.80M | $249.58M | $242.40M | $246.32M | $225.99M | $191.00M |
| Short-term debt | $13.93M | $13.92M | $13.98M | $13.97M | $13.96M | $14.82M | $14.81M | $14.80M |
| Long-term debt | $2.12B | $2.13B | $2.12B | $2.13B | $2.13B | $2.20B | $2.21B | $2.21B |
| Total debt | $2.14B | $2.14B | $2.14B | $2.14B | $2.14B | $2.22B | $2.22B | $2.22B |
| Total liabilities | $2.65B | $2.64B | $2.61B | $2.66B | $2.64B | $2.71B | $2.68B | $2.67B |
| Shareholders' equity | $733.24M | $665.65M | $622.50M | $606.03M | $550.47M | $511.28M | $414.09M | $404.91M |
| Net debt | $1.72B | $1.78B | $1.82B | $1.80B | $1.84B | $1.88B | $1.91B | $1.94B |
| Cash flow statement | ||||||||
| Operating cash flow | $110.55M | $88.50M | $29.43M | $103.10M | $71.15M | $57.42M | $55.52M | $55.72M |
| Capital expenditure | $52.84M | $46.45M | $46.17M | $50.70M | $36.17M | $31.23M | $19.92M | $65.87M |
| Free cash flow | $57.71M | $42.05M | -$16.73M | $52.41M | $34.98M | $26.19M | $35.60M | -$10.15M |
| Investing cash flow | -$51.75M | -$43.30M | -$45.13M | -$50.70M | -$33.34M | -$31.23M | -$19.88M | -$65.87M |
| Financing cash flow | -$1.79M | -$2.40M | -$12.78M | -$8.18M | -$77.34M | -$6.93M | -$8.09M | -$6.55M |
| Depreciation & amortization | $26.99M | $27.83M | $25.21M | $26.97M | $22.71M | $23.09M | $22.13M | $20.71M |
| Stock-based compensation | $7.73M | $7.22M | $14.39M | $7.57M | $7.95M | $8.12M | $7.24M | $8.14M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.